How To Use CPT Code 0708T

CPT 0708T describes the process of intradermal cancer immunotherapy, specifically the preparation and initial injection. This article will provide an overview of CPT code 0708T, including its official description, the procedure involved, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples.

1. What is CPT Code 0708T?

CPT 0708T is a specific code used to describe the preparation and initial injection of intradermal cancer immunotherapy. This procedure involves the provider assembling the necessary equipment and preparing the immunotherapy for injection. The provider then selects an appropriate area on the patient’s skin, cleanses the area, and inserts the needle within the skin layers to administer the immunotherapy solution. This code is specifically for the preparation and initial injection process.

2. Official Description

The official description of CPT code 0708T is: ‘Intradermal cancer immunotherapy; preparation and initial injection.’

3. Procedure

1. The provider assembles the equipment and prepares the immunotherapy for injection.
2. The provider selects the area on the patient’s skin for injection and cleanses the area.
3. The provider places the needle almost flat against the patient’s skin and inserts the needle within the skin layers (intradermal).
4. The provider slowly injects the immunotherapy solution into the intradermal space.
5. The provider withdraws the needle after the injection is complete.

4. Qualifying circumstances

CPT 0708T is applicable when intradermal cancer immunotherapy is being performed. This code is specifically for the preparation and initial injection of the immunotherapy. It is important to note that this code should only be used for the initial injection and not for subsequent injections. The provider must ensure that the immunotherapy is being administered intradermally and that the procedure is performed according to the specific guidelines outlined in the code description.

5. When to use CPT code 0708T

CPT code 0708T should be used when the provider is preparing and administering the initial intradermal injection of cancer immunotherapy. It is important to accurately document the procedure to support the use of this code. If additional injections are performed, CPT code 0709T should be used for each additional injection.

6. Documentation requirements

To support a claim for CPT code 0708T, the provider must document the following information:

• Patient’s diagnosis and the need for intradermal cancer immunotherapy
• Details of the immunotherapy preparation process
• Date and time of the procedure
• Specific location on the patient’s skin where the injection was administered
• Details of the injection technique, including the depth of the intradermal injection
• Signature of the provider performing the procedure

7. Billing guidelines

When billing for CPT code 0708T, ensure that the procedure meets the specific criteria outlined in the code description. It is important to accurately report the preparation and initial injection of intradermal cancer immunotherapy. If additional injections are performed, use CPT code 0709T for each additional injection. It is also important to follow any additional guidelines provided by payers or coding authorities regarding the reporting of this code.

8. Historical information

CPT code 0708T was added to the Current Procedural Terminology system on January 1, 2022. As a relatively new code, there have been no updates or changes since its addition.

9. Examples

1. A healthcare provider prepares the immunotherapy and administers the initial intradermal injection to a patient with skin cancer.
2. During a clinic visit, a provider prepares and performs the initial intradermal injection of cancer immunotherapy for a patient with melanoma.
3. A provider administers the first intradermal injection of cancer immunotherapy to a patient with breast cancer.
4. As part of a clinical trial, a healthcare provider prepares and administers the initial intradermal injection of cancer immunotherapy to a patient with lung cancer.
5. A provider performs the initial intradermal injection of cancer immunotherapy for a patient with lymphoma.
6. During a hospital visit, a healthcare provider prepares and administers the first intradermal injection of cancer immunotherapy to a patient with leukemia.
7. A provider administers the initial intradermal injection of cancer immunotherapy to a patient with prostate cancer.
8. As part of a research study, a healthcare provider prepares and performs the first intradermal injection of cancer immunotherapy for a patient with ovarian cancer.
9. A provider administers the initial intradermal injection of cancer immunotherapy to a patient with pancreatic cancer.
10. During a specialized clinic visit, a healthcare provider prepares and administers the first intradermal injection of cancer immunotherapy to a patient with colorectal cancer.